Darren Ji
MD, PhD, MBA
Chief Executive Officer

Formerly, Bioscience Business Development Executive , Procter & Gamble Company; Responsible for multiple large deals in life science between P&G and East Asian countries; Seasoned leader in pharmaceutical R&D project management.

Jeff Duan
MD
General Manager

Formerly, Head of Pharmacology, Hutchison Medipharma (Shanghai); US board-certified MD; Extensive drug R & D experience in US and China biotech industry. Board member of Shanghai Experimental Animal Committee; Successful Submission of US and China INDs.

Mei-Shu Shih
DVM, PhD
Chief Scientific Officer

Formerly, Research Director of SkeleTech/ MDS and a research veterinary pathologist familiar with GLP operations; Over 25 years in research and specialized contract research services; Highly published and recognized in global bone professional communities.

Tom Tillotson

VP of Corporate Planning

A successful repeater entrepreneur with deep experience in operation and corporate planning. Successful history of managing international businesses, particularly across the US and Asia.

Brian Travers 

Financial Director

Formerly, Senior Manager – Finance and Administration for the International Clinical Diagnostics Operations of Thermo Fisher Scientific. Brian brings extensive international financial management experience having previously been based in the USA, France, and Germany.

Cheng He Jin
MD, PhD
VP of Business Development

Formerly, an executive at Imagene Co Ltd; With a track record of success in multimillion dollar international collaboration deal and more than15 years experience in bioscience and business development.

Kevin (Hong) Zhang   
MD
VP of Pharmacology

Formerly held several Director and Associate Director-level positions in the areas of Drug Discovery, Pharmacology, GeneTrove (drug targets), and Pre-clinical Development for Isis. An innovator in the field of drug technologies, with more than 50 patents issued or filed.